nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—pancreatic cancer—germ cell cancer	0.429	1	CtDrD
Sunitinib—KIT—germ cell cancer	0.187	1	CbGaD
Sunitinib—ABCG2—Dactinomycin—germ cell cancer	0.012	0.101	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.0105	0.0879	CbGbCtD
Sunitinib—CYP3A7—Ifosfamide—germ cell cancer	0.0105	0.0879	CbGbCtD
Sunitinib—ABCC4—Methotrexate—germ cell cancer	0.00833	0.0699	CbGbCtD
Sunitinib—ABCC2—Vinblastine—germ cell cancer	0.00833	0.0698	CbGbCtD
Sunitinib—CYP3A5—Ifosfamide—germ cell cancer	0.00786	0.0659	CbGbCtD
Sunitinib—ABCC2—Cisplatin—germ cell cancer	0.00763	0.064	CbGbCtD
Sunitinib—ABCC2—Etoposide—germ cell cancer	0.0075	0.0629	CbGbCtD
Sunitinib—ABCG2—Cisplatin—germ cell cancer	0.0069	0.0579	CbGbCtD
Sunitinib—ABCG2—Etoposide—germ cell cancer	0.00678	0.0569	CbGbCtD
Sunitinib—ABCC2—Methotrexate—germ cell cancer	0.00496	0.0416	CbGbCtD
Sunitinib—ABCG2—Methotrexate—germ cell cancer	0.00448	0.0376	CbGbCtD
Sunitinib—ABCB1—Dactinomycin—germ cell cancer	0.00433	0.0363	CbGbCtD
Sunitinib—CYP3A5—Etoposide—germ cell cancer	0.00376	0.0315	CbGbCtD
Sunitinib—CYP3A4—Ifosfamide—germ cell cancer	0.00307	0.0257	CbGbCtD
Sunitinib—ABCB1—Vinblastine—germ cell cancer	0.00271	0.0228	CbGbCtD
Sunitinib—ABCB1—Cisplatin—germ cell cancer	0.00249	0.0209	CbGbCtD
Sunitinib—ABCB1—Etoposide—germ cell cancer	0.00245	0.0205	CbGbCtD
Sunitinib—CYP3A4—Vinblastine—germ cell cancer	0.00163	0.0136	CbGbCtD
Sunitinib—ABCB1—Methotrexate—germ cell cancer	0.00162	0.0135	CbGbCtD
Sunitinib—CYP3A4—Etoposide—germ cell cancer	0.00147	0.0123	CbGbCtD
Sunitinib—Procainamide—SLC22A3—germ cell cancer	0.00101	1	CrCbGaD
Sunitinib—STK24—Teniposide—Etoposide—germ cell cancer	0.000669	0.351	CbGdCrCtD
Sunitinib—CHEK2—Vindesine—Vinblastine—germ cell cancer	0.000298	0.156	CbGdCrCtD
Sunitinib—PLK4—Teniposide—Etoposide—germ cell cancer	0.000213	0.112	CbGdCrCtD
Sunitinib—CHEK2—Vinorelbine—Vinblastine—germ cell cancer	0.000188	0.0987	CbGdCrCtD
Sunitinib—CHEK2—Podofilox—Etoposide—germ cell cancer	0.000188	0.0986	CbGdCrCtD
Sunitinib—CHEK2—Teniposide—Etoposide—germ cell cancer	0.000188	0.0986	CbGdCrCtD
Sunitinib—CHEK2—Vincristine—Vinblastine—germ cell cancer	0.000161	0.0844	CbGdCrCtD
Sunitinib—Myalgia—Bleomycin—germ cell cancer	8.78e-05	0.00116	CcSEcCtD
Sunitinib—Renal failure—Etoposide—germ cell cancer	8.75e-05	0.00116	CcSEcCtD
Sunitinib—Neuropathy peripheral—Etoposide—germ cell cancer	8.73e-05	0.00115	CcSEcCtD
Sunitinib—Stomatitis—Etoposide—germ cell cancer	8.68e-05	0.00115	CcSEcCtD
Sunitinib—Decreased appetite—Vinblastine—germ cell cancer	8.66e-05	0.00114	CcSEcCtD
Sunitinib—Neoplasm—Methotrexate—germ cell cancer	8.62e-05	0.00114	CcSEcCtD
Sunitinib—Mouth ulceration—Methotrexate—germ cell cancer	8.62e-05	0.00114	CcSEcCtD
Sunitinib—Urinary tract disorder—Cisplatin—germ cell cancer	8.62e-05	0.00114	CcSEcCtD
Sunitinib—Leukopenia—Dactinomycin—germ cell cancer	8.61e-05	0.00114	CcSEcCtD
Sunitinib—Connective tissue disorder—Cisplatin—germ cell cancer	8.57e-05	0.00113	CcSEcCtD
Sunitinib—Urethral disorder—Cisplatin—germ cell cancer	8.55e-05	0.00113	CcSEcCtD
Sunitinib—Constipation—Vinblastine—germ cell cancer	8.52e-05	0.00112	CcSEcCtD
Sunitinib—Pain—Vinblastine—germ cell cancer	8.52e-05	0.00112	CcSEcCtD
Sunitinib—Pulmonary oedema—Methotrexate—germ cell cancer	8.49e-05	0.00112	CcSEcCtD
Sunitinib—Hepatobiliary disease—Etoposide—germ cell cancer	8.42e-05	0.00111	CcSEcCtD
Sunitinib—Oedema—Bleomycin—germ cell cancer	8.41e-05	0.00111	CcSEcCtD
Sunitinib—Infection—Bleomycin—germ cell cancer	8.36e-05	0.0011	CcSEcCtD
Sunitinib—Sepsis—Methotrexate—germ cell cancer	8.27e-05	0.00109	CcSEcCtD
Sunitinib—Thrombocytopenia—Bleomycin—germ cell cancer	8.24e-05	0.00109	CcSEcCtD
Sunitinib—Myalgia—Dactinomycin—germ cell cancer	8.19e-05	0.00108	CcSEcCtD
Sunitinib—Eye disorder—Cisplatin—germ cell cancer	8.15e-05	0.00108	CcSEcCtD
Sunitinib—Gastrointestinal pain—Vinblastine—germ cell cancer	8.15e-05	0.00108	CcSEcCtD
Sunitinib—Anaemia—Ifosfamide—germ cell cancer	8.14e-05	0.00107	CcSEcCtD
Sunitinib—Cardiac disorder—Cisplatin—germ cell cancer	8.1e-05	0.00107	CcSEcCtD
Sunitinib—Flushing—Cisplatin—germ cell cancer	8.1e-05	0.00107	CcSEcCtD
Sunitinib—Angioedema—Ifosfamide—germ cell cancer	8.05e-05	0.00106	CcSEcCtD
Sunitinib—Anorexia—Bleomycin—germ cell cancer	8.02e-05	0.00106	CcSEcCtD
Sunitinib—Hypoaesthesia—Etoposide—germ cell cancer	7.95e-05	0.00105	CcSEcCtD
Sunitinib—Urinary tract disorder—Etoposide—germ cell cancer	7.89e-05	0.00104	CcSEcCtD
Sunitinib—Leukopenia—Ifosfamide—germ cell cancer	7.89e-05	0.00104	CcSEcCtD
Sunitinib—Immune system disorder—Cisplatin—germ cell cancer	7.88e-05	0.00104	CcSEcCtD
Sunitinib—Abdominal pain—Vinblastine—germ cell cancer	7.88e-05	0.00104	CcSEcCtD
Sunitinib—Mediastinal disorder—Cisplatin—germ cell cancer	7.86e-05	0.00104	CcSEcCtD
Sunitinib—Oedema—Dactinomycin—germ cell cancer	7.85e-05	0.00104	CcSEcCtD
Sunitinib—Urethral disorder—Etoposide—germ cell cancer	7.84e-05	0.00103	CcSEcCtD
Sunitinib—Infection—Dactinomycin—germ cell cancer	7.8e-05	0.00103	CcSEcCtD
Sunitinib—Arrhythmia—Cisplatin—germ cell cancer	7.8e-05	0.00103	CcSEcCtD
Sunitinib—Alopecia—Cisplatin—germ cell cancer	7.71e-05	0.00102	CcSEcCtD
Sunitinib—Hepatic failure—Methotrexate—germ cell cancer	7.7e-05	0.00102	CcSEcCtD
Sunitinib—Cough—Ifosfamide—germ cell cancer	7.69e-05	0.00101	CcSEcCtD
Sunitinib—Thrombocytopenia—Dactinomycin—germ cell cancer	7.68e-05	0.00101	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Bleomycin—germ cell cancer	7.67e-05	0.00101	CcSEcCtD
Sunitinib—Convulsion—Ifosfamide—germ cell cancer	7.63e-05	0.00101	CcSEcCtD
Sunitinib—Hypertension—Ifosfamide—germ cell cancer	7.61e-05	0.001	CcSEcCtD
Sunitinib—Malnutrition—Cisplatin—germ cell cancer	7.6e-05	0.001	CcSEcCtD
Sunitinib—Erythema—Cisplatin—germ cell cancer	7.6e-05	0.001	CcSEcCtD
Sunitinib—Erythema multiforme—Etoposide—germ cell cancer	7.56e-05	0.000997	CcSEcCtD
Sunitinib—Paraesthesia—Bleomycin—germ cell cancer	7.56e-05	0.000997	CcSEcCtD
Sunitinib—Dyspnoea—Bleomycin—germ cell cancer	7.5e-05	0.00099	CcSEcCtD
Sunitinib—Chest pain—Ifosfamide—germ cell cancer	7.5e-05	0.00099	CcSEcCtD
Sunitinib—Myalgia—Ifosfamide—germ cell cancer	7.5e-05	0.00099	CcSEcCtD
Sunitinib—Arthralgia—Ifosfamide—germ cell cancer	7.5e-05	0.00099	CcSEcCtD
Sunitinib—Renal failure acute—Methotrexate—germ cell cancer	7.5e-05	0.000989	CcSEcCtD
Sunitinib—Flatulence—Cisplatin—germ cell cancer	7.49e-05	0.000988	CcSEcCtD
Sunitinib—Anorexia—Dactinomycin—germ cell cancer	7.48e-05	0.000987	CcSEcCtD
Sunitinib—Eye disorder—Etoposide—germ cell cancer	7.47e-05	0.000986	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	7.45e-05	0.000983	CcSEcCtD
Sunitinib—Cardiac disorder—Etoposide—germ cell cancer	7.42e-05	0.000979	CcSEcCtD
Sunitinib—Flushing—Etoposide—germ cell cancer	7.42e-05	0.000979	CcSEcCtD
Sunitinib—Hypersensitivity—Vinblastine—germ cell cancer	7.34e-05	0.000969	CcSEcCtD
Sunitinib—Decreased appetite—Bleomycin—germ cell cancer	7.31e-05	0.000965	CcSEcCtD
Sunitinib—Muscle spasms—Cisplatin—germ cell cancer	7.3e-05	0.000964	CcSEcCtD
Sunitinib—Angiopathy—Etoposide—germ cell cancer	7.25e-05	0.000957	CcSEcCtD
Sunitinib—Immune system disorder—Etoposide—germ cell cancer	7.22e-05	0.000953	CcSEcCtD
Sunitinib—Mediastinal disorder—Etoposide—germ cell cancer	7.2e-05	0.000951	CcSEcCtD
Sunitinib—Pain—Bleomycin—germ cell cancer	7.2e-05	0.00095	CcSEcCtD
Sunitinib—Oedema—Ifosfamide—germ cell cancer	7.19e-05	0.000949	CcSEcCtD
Sunitinib—Chills—Etoposide—germ cell cancer	7.17e-05	0.000947	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	7.15e-05	0.000943	CcSEcCtD
Sunitinib—Asthenia—Vinblastine—germ cell cancer	7.15e-05	0.000943	CcSEcCtD
Sunitinib—Infection—Ifosfamide—germ cell cancer	7.14e-05	0.000943	CcSEcCtD
Sunitinib—Alopecia—Etoposide—germ cell cancer	7.06e-05	0.000932	CcSEcCtD
Sunitinib—Cerebrovascular accident—Methotrexate—germ cell cancer	7.06e-05	0.000932	CcSEcCtD
Sunitinib—Nervous system disorder—Ifosfamide—germ cell cancer	7.05e-05	0.000931	CcSEcCtD
Sunitinib—Thrombocytopenia—Ifosfamide—germ cell cancer	7.04e-05	0.000929	CcSEcCtD
Sunitinib—Anaemia—Cisplatin—germ cell cancer	7.02e-05	0.000926	CcSEcCtD
Sunitinib—Skin disorder—Ifosfamide—germ cell cancer	6.98e-05	0.000922	CcSEcCtD
Sunitinib—Anorexia—Ifosfamide—germ cell cancer	6.85e-05	0.000905	CcSEcCtD
Sunitinib—Decreased appetite—Dactinomycin—germ cell cancer	6.82e-05	0.0009	CcSEcCtD
Sunitinib—Diarrhoea—Vinblastine—germ cell cancer	6.82e-05	0.0009	CcSEcCtD
Sunitinib—Dysgeusia—Etoposide—germ cell cancer	6.81e-05	0.000899	CcSEcCtD
Sunitinib—Leukopenia—Cisplatin—germ cell cancer	6.8e-05	0.000897	CcSEcCtD
Sunitinib—Fatigue—Dactinomycin—germ cell cancer	6.77e-05	0.000893	CcSEcCtD
Sunitinib—Back pain—Etoposide—germ cell cancer	6.73e-05	0.000888	CcSEcCtD
Sunitinib—Pain—Dactinomycin—germ cell cancer	6.71e-05	0.000886	CcSEcCtD
Sunitinib—Muscle spasms—Etoposide—germ cell cancer	6.69e-05	0.000883	CcSEcCtD
Sunitinib—Body temperature increased—Bleomycin—germ cell cancer	6.65e-05	0.000878	CcSEcCtD
Sunitinib—Dizziness—Vinblastine—germ cell cancer	6.59e-05	0.000869	CcSEcCtD
Sunitinib—Convulsion—Cisplatin—germ cell cancer	6.58e-05	0.000869	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	6.55e-05	0.000865	CcSEcCtD
Sunitinib—Myalgia—Cisplatin—germ cell cancer	6.47e-05	0.000853	CcSEcCtD
Sunitinib—Paraesthesia—Ifosfamide—germ cell cancer	6.46e-05	0.000852	CcSEcCtD
Sunitinib—Anaemia—Etoposide—germ cell cancer	6.43e-05	0.000849	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	6.42e-05	0.000848	CcSEcCtD
Sunitinib—Gastrointestinal pain—Dactinomycin—germ cell cancer	6.42e-05	0.000847	CcSEcCtD
Sunitinib—Dyspnoea—Ifosfamide—germ cell cancer	6.41e-05	0.000846	CcSEcCtD
Sunitinib—Liver function test abnormal—Methotrexate—germ cell cancer	6.39e-05	0.000843	CcSEcCtD
Sunitinib—Vomiting—Vinblastine—germ cell cancer	6.33e-05	0.000836	CcSEcCtD
Sunitinib—Decreased appetite—Ifosfamide—germ cell cancer	6.25e-05	0.000825	CcSEcCtD
Sunitinib—Headache—Vinblastine—germ cell cancer	6.24e-05	0.000824	CcSEcCtD
Sunitinib—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	6.23e-05	0.000823	CcSEcCtD
Sunitinib—Leukopenia—Etoposide—germ cell cancer	6.23e-05	0.000822	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Ifosfamide—germ cell cancer	6.21e-05	0.000819	CcSEcCtD
Sunitinib—Abdominal pain—Dactinomycin—germ cell cancer	6.2e-05	0.000819	CcSEcCtD
Sunitinib—Body temperature increased—Dactinomycin—germ cell cancer	6.2e-05	0.000819	CcSEcCtD
Sunitinib—Fatigue—Ifosfamide—germ cell cancer	6.2e-05	0.000818	CcSEcCtD
Sunitinib—Oedema—Cisplatin—germ cell cancer	6.2e-05	0.000818	CcSEcCtD
Sunitinib—Hypersensitivity—Bleomycin—germ cell cancer	6.2e-05	0.000818	CcSEcCtD
Sunitinib—Infection—Cisplatin—germ cell cancer	6.16e-05	0.000813	CcSEcCtD
Sunitinib—Pain—Ifosfamide—germ cell cancer	6.15e-05	0.000811	CcSEcCtD
Sunitinib—Constipation—Ifosfamide—germ cell cancer	6.15e-05	0.000811	CcSEcCtD
Sunitinib—Nervous system disorder—Cisplatin—germ cell cancer	6.08e-05	0.000802	CcSEcCtD
Sunitinib—Cough—Etoposide—germ cell cancer	6.07e-05	0.000801	CcSEcCtD
Sunitinib—Thrombocytopenia—Cisplatin—germ cell cancer	6.07e-05	0.000801	CcSEcCtD
Sunitinib—Asthenia—Bleomycin—germ cell cancer	6.04e-05	0.000797	CcSEcCtD
Sunitinib—Convulsion—Etoposide—germ cell cancer	6.03e-05	0.000796	CcSEcCtD
Sunitinib—Skin disorder—Cisplatin—germ cell cancer	6.02e-05	0.000795	CcSEcCtD
Sunitinib—Hypertension—Etoposide—germ cell cancer	6.01e-05	0.000793	CcSEcCtD
Sunitinib—Pruritus—Bleomycin—germ cell cancer	5.95e-05	0.000786	CcSEcCtD
Sunitinib—Chest pain—Etoposide—germ cell cancer	5.92e-05	0.000782	CcSEcCtD
Sunitinib—Nausea—Vinblastine—germ cell cancer	5.92e-05	0.000781	CcSEcCtD
Sunitinib—Anorexia—Cisplatin—germ cell cancer	5.91e-05	0.00078	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	5.88e-05	0.000776	CcSEcCtD
Sunitinib—Gastrointestinal pain—Ifosfamide—germ cell cancer	5.88e-05	0.000776	CcSEcCtD
Sunitinib—Pancreatitis—Methotrexate—germ cell cancer	5.87e-05	0.000774	CcSEcCtD
Sunitinib—Hypersensitivity—Dactinomycin—germ cell cancer	5.78e-05	0.000763	CcSEcCtD
Sunitinib—Abdominal discomfort—Methotrexate—germ cell cancer	5.74e-05	0.000757	CcSEcCtD
Sunitinib—Body temperature increased—Ifosfamide—germ cell cancer	5.68e-05	0.00075	CcSEcCtD
Sunitinib—Abdominal pain—Ifosfamide—germ cell cancer	5.68e-05	0.00075	CcSEcCtD
Sunitinib—Pancytopenia—Methotrexate—germ cell cancer	5.68e-05	0.00075	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Cisplatin—germ cell cancer	5.65e-05	0.000745	CcSEcCtD
Sunitinib—Infection—Etoposide—germ cell cancer	5.64e-05	0.000745	CcSEcCtD
Sunitinib—Asthenia—Dactinomycin—germ cell cancer	5.63e-05	0.000743	CcSEcCtD
Sunitinib—Neutropenia—Methotrexate—germ cell cancer	5.59e-05	0.000738	CcSEcCtD
Sunitinib—Paraesthesia—Cisplatin—germ cell cancer	5.57e-05	0.000735	CcSEcCtD
Sunitinib—Thrombocytopenia—Etoposide—germ cell cancer	5.56e-05	0.000734	CcSEcCtD
Sunitinib—Upper respiratory tract infection—Methotrexate—germ cell cancer	5.56e-05	0.000734	CcSEcCtD
Sunitinib—Dyspnoea—Cisplatin—germ cell cancer	5.53e-05	0.000729	CcSEcCtD
Sunitinib—Skin disorder—Etoposide—germ cell cancer	5.52e-05	0.000728	CcSEcCtD
Sunitinib—Anorexia—Etoposide—germ cell cancer	5.41e-05	0.000714	CcSEcCtD
Sunitinib—Decreased appetite—Cisplatin—germ cell cancer	5.39e-05	0.000711	CcSEcCtD
Sunitinib—Diarrhoea—Dactinomycin—germ cell cancer	5.37e-05	0.000709	CcSEcCtD
Sunitinib—Pneumonia—Methotrexate—germ cell cancer	5.37e-05	0.000708	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Cisplatin—germ cell cancer	5.35e-05	0.000706	CcSEcCtD
Sunitinib—Vomiting—Bleomycin—germ cell cancer	5.35e-05	0.000706	CcSEcCtD
Sunitinib—Infestation NOS—Methotrexate—germ cell cancer	5.33e-05	0.000704	CcSEcCtD
Sunitinib—Infestation—Methotrexate—germ cell cancer	5.33e-05	0.000704	CcSEcCtD
Sunitinib—Depression—Methotrexate—germ cell cancer	5.32e-05	0.000702	CcSEcCtD
Sunitinib—Rash—Bleomycin—germ cell cancer	5.31e-05	0.0007	CcSEcCtD
Sunitinib—Pain—Cisplatin—germ cell cancer	5.3e-05	0.0007	CcSEcCtD
Sunitinib—Dermatitis—Bleomycin—germ cell cancer	5.3e-05	0.000699	CcSEcCtD
Sunitinib—Hypersensitivity—Ifosfamide—germ cell cancer	5.3e-05	0.000699	CcSEcCtD
Sunitinib—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	5.29e-05	0.000698	CcSEcCtD
Sunitinib—Renal failure—Methotrexate—germ cell cancer	5.24e-05	0.000692	CcSEcCtD
Sunitinib—Stomatitis—Methotrexate—germ cell cancer	5.2e-05	0.000686	CcSEcCtD
Sunitinib—Asthenia—Ifosfamide—germ cell cancer	5.16e-05	0.000681	CcSEcCtD
Sunitinib—Paraesthesia—Etoposide—germ cell cancer	5.1e-05	0.000673	CcSEcCtD
Sunitinib—Pruritus—Ifosfamide—germ cell cancer	5.09e-05	0.000671	CcSEcCtD
Sunitinib—Dyspnoea—Etoposide—germ cell cancer	5.06e-05	0.000668	CcSEcCtD
Sunitinib—Hepatobiliary disease—Methotrexate—germ cell cancer	5.04e-05	0.000666	CcSEcCtD
Sunitinib—Epistaxis—Methotrexate—germ cell cancer	5.03e-05	0.000664	CcSEcCtD
Sunitinib—Nausea—Bleomycin—germ cell cancer	5e-05	0.00066	CcSEcCtD
Sunitinib—Vomiting—Dactinomycin—germ cell cancer	4.99e-05	0.000658	CcSEcCtD
Sunitinib—Rash—Dactinomycin—germ cell cancer	4.95e-05	0.000653	CcSEcCtD
Sunitinib—Decreased appetite—Etoposide—germ cell cancer	4.94e-05	0.000652	CcSEcCtD
Sunitinib—Diarrhoea—Ifosfamide—germ cell cancer	4.92e-05	0.000649	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Etoposide—germ cell cancer	4.9e-05	0.000647	CcSEcCtD
Sunitinib—Body temperature increased—Cisplatin—germ cell cancer	4.9e-05	0.000647	CcSEcCtD
Sunitinib—Fatigue—Etoposide—germ cell cancer	4.9e-05	0.000646	CcSEcCtD
Sunitinib—Pain—Etoposide—germ cell cancer	4.86e-05	0.000641	CcSEcCtD
Sunitinib—Constipation—Etoposide—germ cell cancer	4.86e-05	0.000641	CcSEcCtD
Sunitinib—Haemoglobin—Methotrexate—germ cell cancer	4.81e-05	0.000635	CcSEcCtD
Sunitinib—Hepatitis—Methotrexate—germ cell cancer	4.79e-05	0.000632	CcSEcCtD
Sunitinib—Haemorrhage—Methotrexate—germ cell cancer	4.79e-05	0.000632	CcSEcCtD
Sunitinib—Dizziness—Ifosfamide—germ cell cancer	4.76e-05	0.000628	CcSEcCtD
Sunitinib—Urinary tract disorder—Methotrexate—germ cell cancer	4.73e-05	0.000624	CcSEcCtD
Sunitinib—Urethral disorder—Methotrexate—germ cell cancer	4.69e-05	0.000619	CcSEcCtD
Sunitinib—Nausea—Dactinomycin—germ cell cancer	4.66e-05	0.000615	CcSEcCtD
Sunitinib—Gastrointestinal pain—Etoposide—germ cell cancer	4.64e-05	0.000613	CcSEcCtD
Sunitinib—Vomiting—Ifosfamide—germ cell cancer	4.57e-05	0.000603	CcSEcCtD
Sunitinib—Hypersensitivity—Cisplatin—germ cell cancer	4.57e-05	0.000603	CcSEcCtD
Sunitinib—Rash—Ifosfamide—germ cell cancer	4.53e-05	0.000598	CcSEcCtD
Sunitinib—Dermatitis—Ifosfamide—germ cell cancer	4.53e-05	0.000598	CcSEcCtD
Sunitinib—Erythema multiforme—Methotrexate—germ cell cancer	4.53e-05	0.000597	CcSEcCtD
Sunitinib—Body temperature increased—Etoposide—germ cell cancer	4.49e-05	0.000592	CcSEcCtD
Sunitinib—Abdominal pain—Etoposide—germ cell cancer	4.49e-05	0.000592	CcSEcCtD
Sunitinib—Eye disorder—Methotrexate—germ cell cancer	4.47e-05	0.000591	CcSEcCtD
Sunitinib—Asthenia—Cisplatin—germ cell cancer	4.45e-05	0.000587	CcSEcCtD
Sunitinib—Cardiac disorder—Methotrexate—germ cell cancer	4.44e-05	0.000586	CcSEcCtD
Sunitinib—Angiopathy—Methotrexate—germ cell cancer	4.34e-05	0.000573	CcSEcCtD
Sunitinib—Immune system disorder—Methotrexate—germ cell cancer	4.33e-05	0.000571	CcSEcCtD
Sunitinib—Mediastinal disorder—Methotrexate—germ cell cancer	4.32e-05	0.000569	CcSEcCtD
Sunitinib—Chills—Methotrexate—germ cell cancer	4.3e-05	0.000567	CcSEcCtD
Sunitinib—Nausea—Ifosfamide—germ cell cancer	4.27e-05	0.000564	CcSEcCtD
Sunitinib—Diarrhoea—Cisplatin—germ cell cancer	4.24e-05	0.00056	CcSEcCtD
Sunitinib—Alopecia—Methotrexate—germ cell cancer	4.23e-05	0.000558	CcSEcCtD
Sunitinib—Mental disorder—Methotrexate—germ cell cancer	4.2e-05	0.000554	CcSEcCtD
Sunitinib—Hypersensitivity—Etoposide—germ cell cancer	4.18e-05	0.000552	CcSEcCtD
Sunitinib—Erythema—Methotrexate—germ cell cancer	4.17e-05	0.00055	CcSEcCtD
Sunitinib—Malnutrition—Methotrexate—germ cell cancer	4.17e-05	0.00055	CcSEcCtD
Sunitinib—Dysgeusia—Methotrexate—germ cell cancer	4.08e-05	0.000539	CcSEcCtD
Sunitinib—Asthenia—Etoposide—germ cell cancer	4.07e-05	0.000538	CcSEcCtD
Sunitinib—Back pain—Methotrexate—germ cell cancer	4.03e-05	0.000532	CcSEcCtD
Sunitinib—Pruritus—Etoposide—germ cell cancer	4.02e-05	0.00053	CcSEcCtD
Sunitinib—Vomiting—Cisplatin—germ cell cancer	3.94e-05	0.00052	CcSEcCtD
Sunitinib—Rash—Cisplatin—germ cell cancer	3.91e-05	0.000516	CcSEcCtD
Sunitinib—Dermatitis—Cisplatin—germ cell cancer	3.91e-05	0.000515	CcSEcCtD
Sunitinib—Diarrhoea—Etoposide—germ cell cancer	3.89e-05	0.000513	CcSEcCtD
Sunitinib—Anaemia—Methotrexate—germ cell cancer	3.85e-05	0.000508	CcSEcCtD
Sunitinib—Dizziness—Etoposide—germ cell cancer	3.76e-05	0.000496	CcSEcCtD
Sunitinib—Leukopenia—Methotrexate—germ cell cancer	3.73e-05	0.000492	CcSEcCtD
Sunitinib—Nausea—Cisplatin—germ cell cancer	3.68e-05	0.000486	CcSEcCtD
Sunitinib—Cough—Methotrexate—germ cell cancer	3.64e-05	0.00048	CcSEcCtD
Sunitinib—Convulsion—Methotrexate—germ cell cancer	3.61e-05	0.000477	CcSEcCtD
Sunitinib—Vomiting—Etoposide—germ cell cancer	3.61e-05	0.000477	CcSEcCtD
Sunitinib—Rash—Etoposide—germ cell cancer	3.58e-05	0.000473	CcSEcCtD
Sunitinib—Dermatitis—Etoposide—germ cell cancer	3.58e-05	0.000472	CcSEcCtD
Sunitinib—Headache—Etoposide—germ cell cancer	3.56e-05	0.00047	CcSEcCtD
Sunitinib—Chest pain—Methotrexate—germ cell cancer	3.55e-05	0.000468	CcSEcCtD
Sunitinib—Arthralgia—Methotrexate—germ cell cancer	3.55e-05	0.000468	CcSEcCtD
Sunitinib—Myalgia—Methotrexate—germ cell cancer	3.55e-05	0.000468	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	3.52e-05	0.000465	CcSEcCtD
Sunitinib—Infection—Methotrexate—germ cell cancer	3.38e-05	0.000446	CcSEcCtD
Sunitinib—Nausea—Etoposide—germ cell cancer	3.37e-05	0.000445	CcSEcCtD
Sunitinib—Nervous system disorder—Methotrexate—germ cell cancer	3.34e-05	0.00044	CcSEcCtD
Sunitinib—Thrombocytopenia—Methotrexate—germ cell cancer	3.33e-05	0.00044	CcSEcCtD
Sunitinib—Skin disorder—Methotrexate—germ cell cancer	3.3e-05	0.000436	CcSEcCtD
Sunitinib—Anorexia—Methotrexate—germ cell cancer	3.24e-05	0.000428	CcSEcCtD
Sunitinib—IRAK1—cerebellum—germ cell cancer	3.1e-05	0.000318	CbGeAlD
Sunitinib—Musculoskeletal discomfort—Methotrexate—germ cell cancer	3.1e-05	0.000409	CcSEcCtD
Sunitinib—JAK2—testis—germ cell cancer	3.09e-05	0.000317	CbGeAlD
Sunitinib—MAP4K5—head—germ cell cancer	3.09e-05	0.000317	CbGeAlD
Sunitinib—MAP3K3—head—germ cell cancer	3.09e-05	0.000317	CbGeAlD
Sunitinib—NUAK2—brain—germ cell cancer	3.08e-05	0.000316	CbGeAlD
Sunitinib—STK10—female gonad—germ cell cancer	3.08e-05	0.000316	CbGeAlD
Sunitinib—Insomnia—Methotrexate—germ cell cancer	3.08e-05	0.000406	CcSEcCtD
Sunitinib—TAOK3—female gonad—germ cell cancer	3.07e-05	0.000314	CbGeAlD
Sunitinib—MAP3K12—brain—germ cell cancer	3.06e-05	0.000314	CbGeAlD
Sunitinib—MERTK—lymph node—germ cell cancer	3.06e-05	0.000314	CbGeAlD
Sunitinib—Paraesthesia—Methotrexate—germ cell cancer	3.05e-05	0.000403	CcSEcCtD
Sunitinib—FYN—testis—germ cell cancer	3.05e-05	0.000313	CbGeAlD
Sunitinib—PDGFRA—female gonad—germ cell cancer	3.05e-05	0.000312	CbGeAlD
Sunitinib—RPS6KB1—cerebellum—germ cell cancer	3.04e-05	0.000312	CbGeAlD
Sunitinib—Dyspnoea—Methotrexate—germ cell cancer	3.03e-05	0.0004	CcSEcCtD
Sunitinib—RET—cerebellum—germ cell cancer	3.02e-05	0.00031	CbGeAlD
Sunitinib—FLT1—endocrine gland—germ cell cancer	3.02e-05	0.00031	CbGeAlD
Sunitinib—RPS6KA3—brain—germ cell cancer	3.02e-05	0.00031	CbGeAlD
Sunitinib—AXL—cerebellum—germ cell cancer	3.01e-05	0.000309	CbGeAlD
Sunitinib—MAP4K4—lymph node—germ cell cancer	3e-05	0.000308	CbGeAlD
Sunitinib—MAP2K1—brain—germ cell cancer	3e-05	0.000308	CbGeAlD
Sunitinib—KIT—gonad—germ cell cancer	3e-05	0.000307	CbGeAlD
Sunitinib—Dyspepsia—Methotrexate—germ cell cancer	2.99e-05	0.000395	CcSEcCtD
Sunitinib—FLT1—head—germ cell cancer	2.99e-05	0.000306	CbGeAlD
Sunitinib—MAP3K3—testis—germ cell cancer	2.98e-05	0.000306	CbGeAlD
Sunitinib—MAP4K5—testis—germ cell cancer	2.98e-05	0.000306	CbGeAlD
Sunitinib—NUAK2—lymph node—germ cell cancer	2.98e-05	0.000306	CbGeAlD
Sunitinib—KIT—uterus—germ cell cancer	2.98e-05	0.000305	CbGeAlD
Sunitinib—CSNK1A1—brain—germ cell cancer	2.96e-05	0.000304	CbGeAlD
Sunitinib—MAP3K12—lymph node—germ cell cancer	2.96e-05	0.000303	CbGeAlD
Sunitinib—FLT3—lymph node—germ cell cancer	2.96e-05	0.000303	CbGeAlD
Sunitinib—Decreased appetite—Methotrexate—germ cell cancer	2.96e-05	0.00039	CcSEcCtD
Sunitinib—EPHB6—head—germ cell cancer	2.95e-05	0.000303	CbGeAlD
Sunitinib—KDR—adrenal gland—germ cell cancer	2.95e-05	0.000302	CbGeAlD
Sunitinib—MAP2K5—adrenal gland—germ cell cancer	2.95e-05	0.000302	CbGeAlD
Sunitinib—CLK1—brain—germ cell cancer	2.94e-05	0.000302	CbGeAlD
Sunitinib—Gastrointestinal disorder—Methotrexate—germ cell cancer	2.94e-05	0.000388	CcSEcCtD
Sunitinib—Fatigue—Methotrexate—germ cell cancer	2.93e-05	0.000387	CcSEcCtD
Sunitinib—PDGFRB—gonad—germ cell cancer	2.93e-05	0.0003	CbGeAlD
Sunitinib—KIT—pituitary gland—germ cell cancer	2.92e-05	0.0003	CbGeAlD
Sunitinib—RPS6KA3—lymph node—germ cell cancer	2.92e-05	0.000299	CbGeAlD
Sunitinib—KDR—midbrain—germ cell cancer	2.91e-05	0.000298	CbGeAlD
Sunitinib—MAP2K5—midbrain—germ cell cancer	2.91e-05	0.000298	CbGeAlD
Sunitinib—Pain—Methotrexate—germ cell cancer	2.91e-05	0.000384	CcSEcCtD
Sunitinib—PDGFRB—uterus—germ cell cancer	2.91e-05	0.000298	CbGeAlD
Sunitinib—MAP2K1—lymph node—germ cell cancer	2.9e-05	0.000297	CbGeAlD
Sunitinib—SLK—cerebellum—germ cell cancer	2.9e-05	0.000297	CbGeAlD
Sunitinib—CAMK2G—brain—germ cell cancer	2.89e-05	0.000296	CbGeAlD
Sunitinib—BMP2K—brain—germ cell cancer	2.89e-05	0.000296	CbGeAlD
Sunitinib—YES1—endocrine gland—germ cell cancer	2.89e-05	0.000296	CbGeAlD
Sunitinib—FLT1—testis—germ cell cancer	2.88e-05	0.000296	CbGeAlD
Sunitinib—CSF1R—adrenal gland—germ cell cancer	2.88e-05	0.000295	CbGeAlD
Sunitinib—FGFR2—cerebellum—germ cell cancer	2.87e-05	0.000295	CbGeAlD
Sunitinib—LRRK2—brain—germ cell cancer	2.86e-05	0.000293	CbGeAlD
Sunitinib—STK10—endocrine gland—germ cell cancer	2.86e-05	0.000293	CbGeAlD
Sunitinib—CSNK1A1—lymph node—germ cell cancer	2.86e-05	0.000293	CbGeAlD
Sunitinib—JAK2—cerebellum—germ cell cancer	2.86e-05	0.000293	CbGeAlD
Sunitinib—PDGFRB—pituitary gland—germ cell cancer	2.86e-05	0.000293	CbGeAlD
Sunitinib—KDR—bone marrow—germ cell cancer	2.85e-05	0.000292	CbGeAlD
Sunitinib—YES1—head—germ cell cancer	2.85e-05	0.000292	CbGeAlD
Sunitinib—TAOK3—endocrine gland—germ cell cancer	2.85e-05	0.000292	CbGeAlD
Sunitinib—EPHB6—testis—germ cell cancer	2.85e-05	0.000292	CbGeAlD
Sunitinib—CLK1—lymph node—germ cell cancer	2.84e-05	0.000292	CbGeAlD
Sunitinib—CSF1R—midbrain—germ cell cancer	2.84e-05	0.000291	CbGeAlD
Sunitinib—MAP2K5—spinal cord—germ cell cancer	2.84e-05	0.000291	CbGeAlD
Sunitinib—KDR—spinal cord—germ cell cancer	2.84e-05	0.000291	CbGeAlD
Sunitinib—PDGFRA—endocrine gland—germ cell cancer	2.83e-05	0.00029	CbGeAlD
Sunitinib—STK10—head—germ cell cancer	2.83e-05	0.00029	CbGeAlD
Sunitinib—KCNH2—trigeminal ganglion—germ cell cancer	2.82e-05	0.000289	CbGeAlD
Sunitinib—KIT—medulla oblongata—germ cell cancer	2.82e-05	0.000289	CbGeAlD
Sunitinib—PRKAA1—brain—germ cell cancer	2.82e-05	0.000289	CbGeAlD
Sunitinib—FYN—cerebellum—germ cell cancer	2.82e-05	0.000289	CbGeAlD
Sunitinib—TAOK3—head—germ cell cancer	2.81e-05	0.000289	CbGeAlD
Sunitinib—PDGFRA—head—germ cell cancer	2.8e-05	0.000287	CbGeAlD
Sunitinib—CAMK2G—lymph node—germ cell cancer	2.79e-05	0.000286	CbGeAlD
Sunitinib—BMP2K—lymph node—germ cell cancer	2.79e-05	0.000286	CbGeAlD
Sunitinib—PTK2B—brain—germ cell cancer	2.79e-05	0.000286	CbGeAlD
Sunitinib—CSF1R—bone marrow—germ cell cancer	2.78e-05	0.000285	CbGeAlD
Sunitinib—FLT4—brain—germ cell cancer	2.78e-05	0.000285	CbGeAlD
Sunitinib—Gastrointestinal pain—Methotrexate—germ cell cancer	2.78e-05	0.000367	CcSEcCtD
Sunitinib—CSF1R—spinal cord—germ cell cancer	2.77e-05	0.000284	CbGeAlD
Sunitinib—LRRK2—lymph node—germ cell cancer	2.77e-05	0.000284	CbGeAlD
Sunitinib—PDGFRB—medulla oblongata—germ cell cancer	2.76e-05	0.000283	CbGeAlD
Sunitinib—MAP3K3—cerebellum—germ cell cancer	2.75e-05	0.000282	CbGeAlD
Sunitinib—MAP4K5—cerebellum—germ cell cancer	2.75e-05	0.000282	CbGeAlD
Sunitinib—YES1—testis—germ cell cancer	2.75e-05	0.000282	CbGeAlD
Sunitinib—KDR—female gonad—germ cell cancer	2.75e-05	0.000282	CbGeAlD
Sunitinib—MAP2K5—female gonad—germ cell cancer	2.75e-05	0.000282	CbGeAlD
Sunitinib—CSNK1E—brain—germ cell cancer	2.74e-05	0.000281	CbGeAlD
Sunitinib—FGFR1—brain—germ cell cancer	2.74e-05	0.000281	CbGeAlD
Sunitinib—STK10—testis—germ cell cancer	2.73e-05	0.00028	CbGeAlD
Sunitinib—PRKAA1—lymph node—germ cell cancer	2.73e-05	0.000279	CbGeAlD
Sunitinib—TAOK3—testis—germ cell cancer	2.72e-05	0.000279	CbGeAlD
Sunitinib—PDGFRA—testis—germ cell cancer	2.7e-05	0.000277	CbGeAlD
Sunitinib—IRAK4—brain—germ cell cancer	2.7e-05	0.000277	CbGeAlD
Sunitinib—PTK2B—lymph node—germ cell cancer	2.7e-05	0.000276	CbGeAlD
Sunitinib—Body temperature increased—Methotrexate—germ cell cancer	2.69e-05	0.000355	CcSEcCtD
Sunitinib—Abdominal pain—Methotrexate—germ cell cancer	2.69e-05	0.000355	CcSEcCtD
Sunitinib—FLT4—lymph node—germ cell cancer	2.69e-05	0.000276	CbGeAlD
Sunitinib—CSF1R—female gonad—germ cell cancer	2.68e-05	0.000275	CbGeAlD
Sunitinib—FLT1—cerebellum—germ cell cancer	2.66e-05	0.000273	CbGeAlD
Sunitinib—CSNK1E—lymph node—germ cell cancer	2.65e-05	0.000272	CbGeAlD
Sunitinib—FGFR1—lymph node—germ cell cancer	2.65e-05	0.000272	CbGeAlD
Sunitinib—MAP2K2—brain—germ cell cancer	2.64e-05	0.000271	CbGeAlD
Sunitinib—ULK3—brain—germ cell cancer	2.64e-05	0.000271	CbGeAlD
Sunitinib—EPHB6—cerebellum—germ cell cancer	2.63e-05	0.00027	CbGeAlD
Sunitinib—MAP3K2—brain—germ cell cancer	2.62e-05	0.000269	CbGeAlD
Sunitinib—KIT—adrenal gland—germ cell cancer	2.61e-05	0.000268	CbGeAlD
Sunitinib—IRAK4—lymph node—germ cell cancer	2.61e-05	0.000268	CbGeAlD
Sunitinib—MAP3K7—brain—germ cell cancer	2.6e-05	0.000266	CbGeAlD
Sunitinib—KIT—midbrain—germ cell cancer	2.58e-05	0.000264	CbGeAlD
Sunitinib—TBK1—brain—germ cell cancer	2.57e-05	0.000263	CbGeAlD
Sunitinib—KDR—endocrine gland—germ cell cancer	2.56e-05	0.000262	CbGeAlD
Sunitinib—MAP2K5—endocrine gland—germ cell cancer	2.56e-05	0.000262	CbGeAlD
Sunitinib—MAP2K2—lymph node—germ cell cancer	2.55e-05	0.000262	CbGeAlD
Sunitinib—ULK3—lymph node—germ cell cancer	2.55e-05	0.000262	CbGeAlD
Sunitinib—TYK2—brain—germ cell cancer	2.55e-05	0.000262	CbGeAlD
Sunitinib—PDGFRB—adrenal gland—germ cell cancer	2.55e-05	0.000262	CbGeAlD
Sunitinib—YES1—cerebellum—germ cell cancer	2.54e-05	0.000261	CbGeAlD
Sunitinib—MAP3K2—lymph node—germ cell cancer	2.53e-05	0.00026	CbGeAlD
Sunitinib—KIT—bone marrow—germ cell cancer	2.53e-05	0.000259	CbGeAlD
Sunitinib—KDR—head—germ cell cancer	2.52e-05	0.000259	CbGeAlD
Sunitinib—MAP2K5—head—germ cell cancer	2.52e-05	0.000259	CbGeAlD
Sunitinib—STK10—cerebellum—germ cell cancer	2.52e-05	0.000258	CbGeAlD
Sunitinib—PDGFRB—midbrain—germ cell cancer	2.52e-05	0.000258	CbGeAlD
Sunitinib—IRAK1—brain—germ cell cancer	2.52e-05	0.000258	CbGeAlD
Sunitinib—KIT—spinal cord—germ cell cancer	2.52e-05	0.000258	CbGeAlD
Sunitinib—TAOK3—cerebellum—germ cell cancer	2.51e-05	0.000257	CbGeAlD
Sunitinib—MAP3K7—lymph node—germ cell cancer	2.51e-05	0.000257	CbGeAlD
Sunitinib—ABCG2—trigeminal ganglion—germ cell cancer	2.51e-05	0.000257	CbGeAlD
Sunitinib—Hypersensitivity—Methotrexate—germ cell cancer	2.51e-05	0.000331	CcSEcCtD
Sunitinib—PDGFRA—cerebellum—germ cell cancer	2.5e-05	0.000256	CbGeAlD
Sunitinib—CSF1R—endocrine gland—germ cell cancer	2.49e-05	0.000256	CbGeAlD
Sunitinib—TBK1—lymph node—germ cell cancer	2.48e-05	0.000254	CbGeAlD
Sunitinib—RPS6KB1—brain—germ cell cancer	2.47e-05	0.000253	CbGeAlD
Sunitinib—PDGFRB—bone marrow—germ cell cancer	2.47e-05	0.000253	CbGeAlD
Sunitinib—TYK2—lymph node—germ cell cancer	2.47e-05	0.000253	CbGeAlD
Sunitinib—CSF1R—head—germ cell cancer	2.46e-05	0.000252	CbGeAlD
Sunitinib—PDGFRB—spinal cord—germ cell cancer	2.46e-05	0.000252	CbGeAlD
Sunitinib—FGR—brain—germ cell cancer	2.46e-05	0.000252	CbGeAlD
Sunitinib—RET—brain—germ cell cancer	2.46e-05	0.000252	CbGeAlD
Sunitinib—AXL—brain—germ cell cancer	2.45e-05	0.000251	CbGeAlD
Sunitinib—Asthenia—Methotrexate—germ cell cancer	2.44e-05	0.000322	CcSEcCtD
Sunitinib—MAP2K5—testis—germ cell cancer	2.44e-05	0.00025	CbGeAlD
Sunitinib—KDR—testis—germ cell cancer	2.44e-05	0.00025	CbGeAlD
Sunitinib—KIT—female gonad—germ cell cancer	2.44e-05	0.00025	CbGeAlD
Sunitinib—IRAK1—lymph node—germ cell cancer	2.43e-05	0.000249	CbGeAlD
Sunitinib—Pruritus—Methotrexate—germ cell cancer	2.41e-05	0.000318	CcSEcCtD
Sunitinib—RPS6KB1—lymph node—germ cell cancer	2.39e-05	0.000245	CbGeAlD
Sunitinib—CSF1R—testis—germ cell cancer	2.38e-05	0.000244	CbGeAlD
Sunitinib—PDGFRB—female gonad—germ cell cancer	2.38e-05	0.000244	CbGeAlD
Sunitinib—FGR—lymph node—germ cell cancer	2.37e-05	0.000243	CbGeAlD
Sunitinib—RET—lymph node—germ cell cancer	2.37e-05	0.000243	CbGeAlD
Sunitinib—AXL—lymph node—germ cell cancer	2.36e-05	0.000242	CbGeAlD
Sunitinib—SLK—brain—germ cell cancer	2.35e-05	0.000241	CbGeAlD
Sunitinib—FGFR2—brain—germ cell cancer	2.33e-05	0.000239	CbGeAlD
Sunitinib—Diarrhoea—Methotrexate—germ cell cancer	2.33e-05	0.000307	CcSEcCtD
Sunitinib—JAK2—brain—germ cell cancer	2.32e-05	0.000238	CbGeAlD
Sunitinib—ABCC4—uterus—germ cell cancer	2.32e-05	0.000237	CbGeAlD
Sunitinib—FYN—brain—germ cell cancer	2.29e-05	0.000235	CbGeAlD
Sunitinib—SLK—lymph node—germ cell cancer	2.28e-05	0.000233	CbGeAlD
Sunitinib—KIT—endocrine gland—germ cell cancer	2.27e-05	0.000232	CbGeAlD
Sunitinib—MAP2K5—cerebellum—germ cell cancer	2.25e-05	0.000231	CbGeAlD
Sunitinib—KDR—cerebellum—germ cell cancer	2.25e-05	0.000231	CbGeAlD
Sunitinib—Dizziness—Methotrexate—germ cell cancer	2.25e-05	0.000297	CcSEcCtD
Sunitinib—JAK2—lymph node—germ cell cancer	2.24e-05	0.00023	CbGeAlD
Sunitinib—MAP4K5—brain—germ cell cancer	2.24e-05	0.000229	CbGeAlD
Sunitinib—MAP3K3—brain—germ cell cancer	2.24e-05	0.000229	CbGeAlD
Sunitinib—KIT—head—germ cell cancer	2.24e-05	0.000229	CbGeAlD
Sunitinib—KCNH2—telencephalon—germ cell cancer	2.22e-05	0.000227	CbGeAlD
Sunitinib—PDGFRB—endocrine gland—germ cell cancer	2.21e-05	0.000227	CbGeAlD
Sunitinib—FYN—lymph node—germ cell cancer	2.21e-05	0.000227	CbGeAlD
Sunitinib—CSF1R—cerebellum—germ cell cancer	2.2e-05	0.000225	CbGeAlD
Sunitinib—PDGFRB—head—germ cell cancer	2.18e-05	0.000224	CbGeAlD
Sunitinib—FLT1—brain—germ cell cancer	2.16e-05	0.000222	CbGeAlD
Sunitinib—Vomiting—Methotrexate—germ cell cancer	2.16e-05	0.000285	CcSEcCtD
Sunitinib—MAP3K3—lymph node—germ cell cancer	2.16e-05	0.000222	CbGeAlD
Sunitinib—MAP4K5—lymph node—germ cell cancer	2.16e-05	0.000222	CbGeAlD
Sunitinib—KIT—testis—germ cell cancer	2.16e-05	0.000221	CbGeAlD
Sunitinib—Rash—Methotrexate—germ cell cancer	2.15e-05	0.000283	CcSEcCtD
Sunitinib—Dermatitis—Methotrexate—germ cell cancer	2.14e-05	0.000283	CcSEcCtD
Sunitinib—EPHB6—brain—germ cell cancer	2.14e-05	0.000219	CbGeAlD
Sunitinib—Headache—Methotrexate—germ cell cancer	2.13e-05	0.000281	CcSEcCtD
Sunitinib—PDGFRB—testis—germ cell cancer	2.11e-05	0.000216	CbGeAlD
Sunitinib—FLT1—lymph node—germ cell cancer	2.09e-05	0.000214	CbGeAlD
Sunitinib—YES1—brain—germ cell cancer	2.07e-05	0.000212	CbGeAlD
Sunitinib—EPHB6—lymph node—germ cell cancer	2.07e-05	0.000212	CbGeAlD
Sunitinib—STK10—brain—germ cell cancer	2.05e-05	0.00021	CbGeAlD
Sunitinib—TAOK3—brain—germ cell cancer	2.04e-05	0.000209	CbGeAlD
Sunitinib—ABCC4—adrenal gland—germ cell cancer	2.03e-05	0.000208	CbGeAlD
Sunitinib—PDGFRA—brain—germ cell cancer	2.03e-05	0.000208	CbGeAlD
Sunitinib—Nausea—Methotrexate—germ cell cancer	2.02e-05	0.000267	CcSEcCtD
Sunitinib—ABCB1—blood vessel—germ cell cancer	2e-05	0.000205	CbGeAlD
Sunitinib—YES1—lymph node—germ cell cancer	2e-05	0.000205	CbGeAlD
Sunitinib—KIT—cerebellum—germ cell cancer	2e-05	0.000205	CbGeAlD
Sunitinib—STK10—lymph node—germ cell cancer	1.98e-05	0.000203	CbGeAlD
Sunitinib—ABCG2—telencephalon—germ cell cancer	1.97e-05	0.000202	CbGeAlD
Sunitinib—TAOK3—lymph node—germ cell cancer	1.97e-05	0.000202	CbGeAlD
Sunitinib—ABCC2—adrenal gland—germ cell cancer	1.97e-05	0.000202	CbGeAlD
Sunitinib—ABCC4—bone marrow—germ cell cancer	1.97e-05	0.000201	CbGeAlD
Sunitinib—PDGFRA—lymph node—germ cell cancer	1.96e-05	0.000201	CbGeAlD
Sunitinib—PDGFRB—cerebellum—germ cell cancer	1.95e-05	0.0002	CbGeAlD
Sunitinib—ABCC4—female gonad—germ cell cancer	1.89e-05	0.000194	CbGeAlD
Sunitinib—ABCG2—decidua—germ cell cancer	1.87e-05	0.000192	CbGeAlD
Sunitinib—KCNH2—uterus—germ cell cancer	1.84e-05	0.000188	CbGeAlD
Sunitinib—KDR—brain—germ cell cancer	1.83e-05	0.000187	CbGeAlD
Sunitinib—MAP2K5—brain—germ cell cancer	1.83e-05	0.000187	CbGeAlD
Sunitinib—KCNH2—pituitary gland—germ cell cancer	1.8e-05	0.000185	CbGeAlD
Sunitinib—CSF1R—brain—germ cell cancer	1.78e-05	0.000183	CbGeAlD
Sunitinib—KDR—lymph node—germ cell cancer	1.77e-05	0.000181	CbGeAlD
Sunitinib—MAP2K5—lymph node—germ cell cancer	1.77e-05	0.000181	CbGeAlD
Sunitinib—ABCC4—endocrine gland—germ cell cancer	1.76e-05	0.000181	CbGeAlD
Sunitinib—KCNH2—medulla oblongata—germ cell cancer	1.74e-05	0.000179	CbGeAlD
Sunitinib—ABCC4—head—germ cell cancer	1.74e-05	0.000178	CbGeAlD
Sunitinib—CSF1R—lymph node—germ cell cancer	1.72e-05	0.000177	CbGeAlD
Sunitinib—ABCC2—endocrine gland—germ cell cancer	1.71e-05	0.000175	CbGeAlD
Sunitinib—ABCC4—testis—germ cell cancer	1.68e-05	0.000172	CbGeAlD
Sunitinib—ABCG2—uterus—germ cell cancer	1.63e-05	0.000168	CbGeAlD
Sunitinib—ABCC2—testis—germ cell cancer	1.63e-05	0.000167	CbGeAlD
Sunitinib—KIT—brain—germ cell cancer	1.62e-05	0.000166	CbGeAlD
Sunitinib—KCNH2—adrenal gland—germ cell cancer	1.61e-05	0.000165	CbGeAlD
Sunitinib—ABCG2—pituitary gland—germ cell cancer	1.61e-05	0.000165	CbGeAlD
Sunitinib—KCNH2—midbrain—germ cell cancer	1.59e-05	0.000163	CbGeAlD
Sunitinib—PDGFRB—brain—germ cell cancer	1.58e-05	0.000162	CbGeAlD
Sunitinib—KIT—lymph node—germ cell cancer	1.57e-05	0.000161	CbGeAlD
Sunitinib—KCNH2—bone marrow—germ cell cancer	1.56e-05	0.00016	CbGeAlD
Sunitinib—KCNH2—spinal cord—germ cell cancer	1.55e-05	0.000159	CbGeAlD
Sunitinib—ABCG2—medulla oblongata—germ cell cancer	1.55e-05	0.000159	CbGeAlD
Sunitinib—PDGFRB—lymph node—germ cell cancer	1.53e-05	0.000157	CbGeAlD
Sunitinib—KCNH2—female gonad—germ cell cancer	1.5e-05	0.000154	CbGeAlD
Sunitinib—ABCG2—adrenal gland—germ cell cancer	1.43e-05	0.000147	CbGeAlD
Sunitinib—ABCG2—midbrain—germ cell cancer	1.42e-05	0.000145	CbGeAlD
Sunitinib—KCNH2—endocrine gland—germ cell cancer	1.4e-05	0.000143	CbGeAlD
Sunitinib—ABCG2—bone marrow—germ cell cancer	1.39e-05	0.000142	CbGeAlD
Sunitinib—ABCG2—spinal cord—germ cell cancer	1.38e-05	0.000142	CbGeAlD
Sunitinib—KCNH2—head—germ cell cancer	1.38e-05	0.000141	CbGeAlD
Sunitinib—ABCG2—female gonad—germ cell cancer	1.34e-05	0.000137	CbGeAlD
Sunitinib—KCNH2—testis—germ cell cancer	1.33e-05	0.000137	CbGeAlD
Sunitinib—ABCC4—brain—germ cell cancer	1.26e-05	0.000129	CbGeAlD
Sunitinib—CYP3A5—female gonad—germ cell cancer	1.24e-05	0.000127	CbGeAlD
Sunitinib—ABCB1—trigeminal ganglion—germ cell cancer	1.24e-05	0.000127	CbGeAlD
Sunitinib—KCNH2—cerebellum—germ cell cancer	1.23e-05	0.000126	CbGeAlD
Sunitinib—ABCC4—lymph node—germ cell cancer	1.22e-05	0.000125	CbGeAlD
Sunitinib—ABCB1—embryo—germ cell cancer	1.2e-05	0.000123	CbGeAlD
Sunitinib—ABCG2—testis—germ cell cancer	1.19e-05	0.000122	CbGeAlD
Sunitinib—ABCC2—lymph node—germ cell cancer	1.18e-05	0.000121	CbGeAlD
Sunitinib—CYP3A5—endocrine gland—germ cell cancer	1.15e-05	0.000118	CbGeAlD
Sunitinib—ABCG2—cerebellum—germ cell cancer	1.1e-05	0.000112	CbGeAlD
Sunitinib—ABCB1—retina—germ cell cancer	1.06e-05	0.000108	CbGeAlD
Sunitinib—KCNH2—brain—germ cell cancer	1e-05	0.000103	CbGeAlD
Sunitinib—ABCB1—telencephalon—germ cell cancer	9.72e-06	9.97e-05	CbGeAlD
Sunitinib—KCNH2—lymph node—germ cell cancer	9.66e-06	9.91e-05	CbGeAlD
Sunitinib—ABCB1—decidua—germ cell cancer	9.21e-06	9.45e-05	CbGeAlD
Sunitinib—ABCG2—brain—germ cell cancer	8.9e-06	9.12e-05	CbGeAlD
Sunitinib—CYP3A4—endocrine gland—germ cell cancer	8.66e-06	8.88e-05	CbGeAlD
Sunitinib—ABCG2—lymph node—germ cell cancer	8.6e-06	8.81e-05	CbGeAlD
Sunitinib—ABCB1—gonad—germ cell cancer	8.11e-06	8.32e-05	CbGeAlD
Sunitinib—ABCB1—uterus—germ cell cancer	8.06e-06	8.26e-05	CbGeAlD
Sunitinib—ABCB1—pituitary gland—germ cell cancer	7.92e-06	8.11e-05	CbGeAlD
Sunitinib—ABCB1—medulla oblongata—germ cell cancer	7.64e-06	7.83e-05	CbGeAlD
Sunitinib—ABCB1—adrenal gland—germ cell cancer	7.07e-06	7.25e-05	CbGeAlD
Sunitinib—ABCB1—midbrain—germ cell cancer	6.98e-06	7.16e-05	CbGeAlD
Sunitinib—ABCB1—bone marrow—germ cell cancer	6.84e-06	7.01e-05	CbGeAlD
Sunitinib—ABCB1—spinal cord—germ cell cancer	6.81e-06	6.98e-05	CbGeAlD
Sunitinib—ABCB1—female gonad—germ cell cancer	6.59e-06	6.76e-05	CbGeAlD
Sunitinib—ABCB1—endocrine gland—germ cell cancer	6.13e-06	6.29e-05	CbGeAlD
Sunitinib—ABCB1—head—germ cell cancer	6.05e-06	6.21e-05	CbGeAlD
Sunitinib—ABCB1—testis—germ cell cancer	5.85e-06	6e-05	CbGeAlD
Sunitinib—ABCB1—cerebellum—germ cell cancer	5.4e-06	5.54e-05	CbGeAlD
Sunitinib—ABCB1—brain—germ cell cancer	4.39e-06	4.5e-05	CbGeAlD
Sunitinib—ABCB1—lymph node—germ cell cancer	4.24e-06	4.35e-05	CbGeAlD
Sunitinib—FGFR1—Signaling Pathways—AVP—germ cell cancer	2.54e-06	2.88e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—FGFR3—germ cell cancer	2.54e-06	2.88e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—H2AFZ—germ cell cancer	2.54e-06	2.88e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—AVP—germ cell cancer	2.53e-06	2.87e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—KIT—germ cell cancer	2.53e-06	2.87e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—KIT—germ cell cancer	2.53e-06	2.86e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—KIT—germ cell cancer	2.53e-06	2.86e-05	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—HRAS—germ cell cancer	2.51e-06	2.84e-05	CbGpPWpGaD
Sunitinib—TYK2—Developmental Biology—HRAS—germ cell cancer	2.5e-06	2.84e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—SLC2A3—germ cell cancer	2.49e-06	2.82e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—FGFR3—germ cell cancer	2.48e-06	2.81e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—KIT—germ cell cancer	2.47e-06	2.8e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—KIT—germ cell cancer	2.47e-06	2.8e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—KIT—germ cell cancer	2.47e-06	2.79e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—FGFR3—germ cell cancer	2.46e-06	2.79e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—MYC—germ cell cancer	2.46e-06	2.79e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—SLC22A3—germ cell cancer	2.45e-06	2.78e-05	CbGpPWpGaD
Sunitinib—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	2.45e-06	2.78e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—H2AFZ—germ cell cancer	2.45e-06	2.77e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Immune System—HRAS—germ cell cancer	2.44e-06	2.77e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—H2AFZ—germ cell cancer	2.43e-06	2.76e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—KIT—germ cell cancer	2.41e-06	2.73e-05	CbGpPWpGaD
Sunitinib—YES1—Innate Immune System—HRAS—germ cell cancer	2.4e-06	2.72e-05	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—TP53—germ cell cancer	2.4e-06	2.72e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—KITLG—germ cell cancer	2.39e-06	2.71e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—MYC—germ cell cancer	2.39e-06	2.71e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Disease—HRAS—germ cell cancer	2.39e-06	2.71e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—FGFR3—germ cell cancer	2.39e-06	2.71e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—FGFR3—germ cell cancer	2.38e-06	2.69e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—KIT—germ cell cancer	2.38e-06	2.69e-05	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	2.37e-06	2.69e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—KIT—germ cell cancer	2.36e-06	2.68e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—AVP—germ cell cancer	2.34e-06	2.65e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—KITLG—germ cell cancer	2.34e-06	2.65e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—KIT—germ cell cancer	2.33e-06	2.64e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—H2AFZ—germ cell cancer	2.33e-06	2.64e-05	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—TP53—germ cell cancer	2.31e-06	2.62e-05	CbGpPWpGaD
Sunitinib—YES1—Adaptive Immune System—HRAS—germ cell cancer	2.31e-06	2.61e-05	CbGpPWpGaD
Sunitinib—FGFR1—Developmental Biology—HRAS—germ cell cancer	2.31e-06	2.61e-05	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—HRAS—germ cell cancer	2.29e-06	2.6e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—AVP—germ cell cancer	2.28e-06	2.59e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—FGFR3—germ cell cancer	2.28e-06	2.58e-05	CbGpPWpGaD
Sunitinib—IRAK1—Innate Immune System—HRAS—germ cell cancer	2.28e-06	2.58e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—KIT—germ cell cancer	2.28e-06	2.58e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—FGFR3—germ cell cancer	2.27e-06	2.57e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—MYC—germ cell cancer	2.26e-06	2.56e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—KIT—germ cell cancer	2.26e-06	2.56e-05	CbGpPWpGaD
Sunitinib—ABCC4—Hemostasis—TP53—germ cell cancer	2.25e-06	2.55e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—KITLG—germ cell cancer	2.25e-06	2.55e-05	CbGpPWpGaD
Sunitinib—TBK1—Immune System—HRAS—germ cell cancer	2.24e-06	2.54e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—KITLG—germ cell cancer	2.24e-06	2.54e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—MYC—germ cell cancer	2.24e-06	2.53e-05	CbGpPWpGaD
Sunitinib—TYK2—Innate Immune System—HRAS—germ cell cancer	2.21e-06	2.51e-05	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—HRAS—germ cell cancer	2.21e-06	2.5e-05	CbGpPWpGaD
Sunitinib—CAMK2G—Immune System—HRAS—germ cell cancer	2.2e-06	2.49e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—AVP—germ cell cancer	2.2e-06	2.49e-05	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—TP53—germ cell cancer	2.19e-06	2.49e-05	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—TP53—germ cell cancer	2.19e-06	2.49e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—KIT—germ cell cancer	2.19e-06	2.49e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—AVP—germ cell cancer	2.19e-06	2.48e-05	CbGpPWpGaD
Sunitinib—FGFR2—Innate Immune System—HRAS—germ cell cancer	2.18e-06	2.47e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—KIT—germ cell cancer	2.18e-06	2.47e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—FGFR3—germ cell cancer	2.16e-06	2.45e-05	CbGpPWpGaD
Sunitinib—ABCC4—Hemostasis—HRAS—germ cell cancer	2.15e-06	2.44e-05	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—HRAS—germ cell cancer	2.15e-06	2.44e-05	CbGpPWpGaD
Sunitinib—KIT—Innate Immune System—HRAS—germ cell cancer	2.15e-06	2.43e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Innate Immune System—HRAS—germ cell cancer	2.15e-06	2.43e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—KITLG—germ cell cancer	2.14e-06	2.42e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—MYC—germ cell cancer	2.13e-06	2.41e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—HRAS—germ cell cancer	2.13e-06	2.41e-05	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—TP53—germ cell cancer	2.13e-06	2.41e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Developmental Biology—HRAS—germ cell cancer	2.12e-06	2.4e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—FGFR3—germ cell cancer	2.1e-06	2.38e-05	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—HRAS—germ cell cancer	2.1e-06	2.38e-05	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—HRAS—germ cell cancer	2.1e-06	2.38e-05	CbGpPWpGaD
Sunitinib—FGFR2—Adaptive Immune System—HRAS—germ cell cancer	2.1e-06	2.38e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—KIT—germ cell cancer	2.09e-06	2.37e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—AVP—germ cell cancer	2.09e-06	2.37e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—KIT—germ cell cancer	2.09e-06	2.36e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—FGFR3—germ cell cancer	2.07e-06	2.35e-05	CbGpPWpGaD
Sunitinib—KIT—Adaptive Immune System—HRAS—germ cell cancer	2.06e-06	2.33e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Adaptive Immune System—HRAS—germ cell cancer	2.06e-06	2.33e-05	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—TP53—germ cell cancer	2.05e-06	2.32e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—FGFR3—germ cell cancer	2.04e-06	2.31e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—FGFR3—germ cell cancer	2.04e-06	2.31e-05	CbGpPWpGaD
Sunitinib—FGFR1—Innate Immune System—HRAS—germ cell cancer	2.04e-06	2.31e-05	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—HRAS—germ cell cancer	2.04e-06	2.31e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—HRAS—germ cell cancer	2.03e-06	2.3e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—MYC—germ cell cancer	2.01e-06	2.28e-05	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—HRAS—germ cell cancer	2e-06	2.26e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CRABP1—germ cell cancer	2e-06	2.26e-05	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—HRAS—germ cell cancer	2e-06	2.26e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—MYC—germ cell cancer	1.99e-06	2.26e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—HRAS—germ cell cancer	1.99e-06	2.25e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—KIT—germ cell cancer	1.99e-06	2.25e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—TP53—germ cell cancer	1.96e-06	2.22e-05	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—HRAS—germ cell cancer	1.96e-06	2.22e-05	CbGpPWpGaD
Sunitinib—FGFR1—Adaptive Immune System—HRAS—germ cell cancer	1.96e-06	2.21e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Adaptive Immune System—HRAS—germ cell cancer	1.95e-06	2.21e-05	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1.95e-06	2.21e-05	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—TP53—germ cell cancer	1.95e-06	2.21e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—HRAS—germ cell cancer	1.94e-06	2.2e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—FGFR3—germ cell cancer	1.93e-06	2.19e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—HRAS—germ cell cancer	1.93e-06	2.19e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—KIT—germ cell cancer	1.93e-06	2.18e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—FGFR3—germ cell cancer	1.93e-06	2.18e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—KIT—germ cell cancer	1.9e-06	2.16e-05	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—HRAS—germ cell cancer	1.9e-06	2.15e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—HRAS—germ cell cancer	1.88e-06	2.13e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—HRAS—germ cell cancer	1.88e-06	2.13e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—HRAS—germ cell cancer	1.87e-06	2.12e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—KIT—germ cell cancer	1.87e-06	2.12e-05	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—HRAS—germ cell cancer	1.86e-06	2.11e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—TP53—germ cell cancer	1.86e-06	2.1e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—TP53—germ cell cancer	1.84e-06	2.08e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—HRAS—germ cell cancer	1.83e-06	2.07e-05	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—HRAS—germ cell cancer	1.78e-06	2.02e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—FGFR3—germ cell cancer	1.78e-06	2.02e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—HRAS—germ cell cancer	1.78e-06	2.01e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—KIT—germ cell cancer	1.77e-06	2.01e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—KIT—germ cell cancer	1.77e-06	2e-05	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—HRAS—germ cell cancer	1.76e-06	2e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—HRAS—germ cell cancer	1.76e-06	1.99e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—HRAS—germ cell cancer	1.76e-06	1.99e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—HRAS—germ cell cancer	1.75e-06	1.99e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—TP53—germ cell cancer	1.75e-06	1.98e-05	CbGpPWpGaD
Sunitinib—BLK—Immune System—HRAS—germ cell cancer	1.74e-06	1.97e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—FGFR3—germ cell cancer	1.74e-06	1.97e-05	CbGpPWpGaD
Sunitinib—FGR—Immune System—HRAS—germ cell cancer	1.73e-06	1.96e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—MYC—germ cell cancer	1.72e-06	1.95e-05	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—HRAS—germ cell cancer	1.69e-06	1.92e-05	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—HRAS—germ cell cancer	1.68e-06	1.9e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—HRAS—germ cell cancer	1.67e-06	1.9e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—FGFR3—germ cell cancer	1.67e-06	1.9e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—FGFR3—germ cell cancer	1.66e-06	1.89e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—TP53—germ cell cancer	1.65e-06	1.87e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—TP53—germ cell cancer	1.64e-06	1.85e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—KIT—germ cell cancer	1.63e-06	1.85e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—MYC—germ cell cancer	1.62e-06	1.83e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—MYC—germ cell cancer	1.6e-06	1.81e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—KIT—germ cell cancer	1.59e-06	1.81e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—FGFR3—germ cell cancer	1.59e-06	1.8e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—HRAS—germ cell cancer	1.58e-06	1.79e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—HRAS—germ cell cancer	1.57e-06	1.77e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—KIT—germ cell cancer	1.54e-06	1.74e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SLC2A3—germ cell cancer	1.53e-06	1.74e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—KIT—germ cell cancer	1.53e-06	1.73e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—MYC—germ cell cancer	1.51e-06	1.72e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SLC22A3—germ cell cancer	1.51e-06	1.71e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—MYC—germ cell cancer	1.5e-06	1.69e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—MYC—germ cell cancer	1.47e-06	1.66e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—MYC—germ cell cancer	1.47e-06	1.66e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—KIT—germ cell cancer	1.46e-06	1.65e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—TP53—germ cell cancer	1.41e-06	1.6e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—MYC—germ cell cancer	1.41e-06	1.6e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—HRAS—germ cell cancer	1.41e-06	1.6e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—MYC—germ cell cancer	1.4e-06	1.59e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—HRAS—germ cell cancer	1.4e-06	1.59e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—MYC—germ cell cancer	1.39e-06	1.58e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—MYC—germ cell cancer	1.39e-06	1.58e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—MYC—germ cell cancer	1.36e-06	1.54e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—MYC—germ cell cancer	1.36e-06	1.54e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—HRAS—germ cell cancer	1.35e-06	1.53e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—HRAS—germ cell cancer	1.33e-06	1.5e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—TP53—germ cell cancer	1.33e-06	1.5e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—MYC—germ cell cancer	1.33e-06	1.5e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—TP53—germ cell cancer	1.31e-06	1.49e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—HRAS—germ cell cancer	1.29e-06	1.46e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—MYC—germ cell cancer	1.28e-06	1.45e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—HRAS—germ cell cancer	1.27e-06	1.44e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—HRAS—germ cell cancer	1.27e-06	1.44e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—HRAS—germ cell cancer	1.26e-06	1.42e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—MYC—germ cell cancer	1.25e-06	1.42e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—HRAS—germ cell cancer	1.25e-06	1.42e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—HRAS—germ cell cancer	1.25e-06	1.42e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CRABP1—germ cell cancer	1.23e-06	1.39e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—MYC—germ cell cancer	1.21e-06	1.37e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—TP53—germ cell cancer	1.2e-06	1.36e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—MYC—germ cell cancer	1.2e-06	1.36e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—HRAS—germ cell cancer	1.2e-06	1.35e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—HRAS—germ cell cancer	1.19e-06	1.35e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—HRAS—germ cell cancer	1.19e-06	1.34e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—HRAS—germ cell cancer	1.18e-06	1.34e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—HRAS—germ cell cancer	1.17e-06	1.33e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TP53—germ cell cancer	1.16e-06	1.31e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—HRAS—germ cell cancer	1.15e-06	1.31e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TP53—germ cell cancer	1.15e-06	1.31e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—HRAS—germ cell cancer	1.15e-06	1.31e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MYC—germ cell cancer	1.15e-06	1.3e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—MYC—germ cell cancer	1.15e-06	1.3e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—HRAS—germ cell cancer	1.12e-06	1.27e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TP53—germ cell cancer	1.12e-06	1.27e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TP53—germ cell cancer	1.12e-06	1.27e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—HRAS—germ cell cancer	1.11e-06	1.26e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—HRAS—germ cell cancer	1.1e-06	1.25e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—HRAS—germ cell cancer	1.09e-06	1.24e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MYC—germ cell cancer	1.09e-06	1.24e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—HRAS—germ cell cancer	1.09e-06	1.24e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—HRAS—germ cell cancer	1.09e-06	1.24e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TP53—germ cell cancer	1.09e-06	1.23e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—HRAS—germ cell cancer	1.07e-06	1.21e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—HRAS—germ cell cancer	1.07e-06	1.21e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—HRAS—germ cell cancer	1.07e-06	1.21e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—HRAS—germ cell cancer	1.07e-06	1.21e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MYC—germ cell cancer	1.06e-06	1.2e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MYC—germ cell cancer	1.05e-06	1.19e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—HRAS—germ cell cancer	1.04e-06	1.18e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MYC—germ cell cancer	1.03e-06	1.17e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MYC—germ cell cancer	1.03e-06	1.17e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—HRAS—germ cell cancer	1.03e-06	1.16e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—HRAS—germ cell cancer	1.02e-06	1.16e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—HRAS—germ cell cancer	1.01e-06	1.14e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—HRAS—germ cell cancer	9.84e-07	1.11e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—HRAS—germ cell cancer	9.76e-07	1.11e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MYC—germ cell cancer	9.76e-07	1.11e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MYC—germ cell cancer	9.74e-07	1.1e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—HRAS—germ cell cancer	9.48e-07	1.07e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TP53—germ cell cancer	9.46e-07	1.07e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—HRAS—germ cell cancer	9.43e-07	1.07e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—HRAS—germ cell cancer	9.05e-07	1.02e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—HRAS—germ cell cancer	9.01e-07	1.02e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MYC—germ cell cancer	8.99e-07	1.02e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TP53—germ cell cancer	8.97e-07	1.02e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MYC—germ cell cancer	8.77e-07	9.94e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TP53—germ cell cancer	8.71e-07	9.87e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TP53—germ cell cancer	8.6e-07	9.74e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—HRAS—germ cell cancer	8.58e-07	9.72e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MYC—germ cell cancer	8.46e-07	9.58e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TP53—germ cell cancer	8.45e-07	9.57e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TP53—germ cell cancer	8.45e-07	9.57e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MYC—germ cell cancer	8.41e-07	9.53e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—HRAS—germ cell cancer	8.33e-07	9.44e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—HRAS—germ cell cancer	8.23e-07	9.32e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—HRAS—germ cell cancer	8.08e-07	9.15e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—HRAS—germ cell cancer	8.08e-07	9.15e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MYC—germ cell cancer	8.04e-07	9.1e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TP53—germ cell cancer	8.02e-07	9.08e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TP53—germ cell cancer	8e-07	9.06e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—HRAS—germ cell cancer	7.67e-07	8.69e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—HRAS—germ cell cancer	7.65e-07	8.66e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TP53—germ cell cancer	7.38e-07	8.36e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TP53—germ cell cancer	7.2e-07	8.16e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—HRAS—germ cell cancer	7.06e-07	8e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TP53—germ cell cancer	6.94e-07	7.87e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TP53—germ cell cancer	6.91e-07	7.82e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—HRAS—germ cell cancer	6.89e-07	7.8e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—HRAS—germ cell cancer	6.64e-07	7.52e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—HRAS—germ cell cancer	6.61e-07	7.48e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TP53—germ cell cancer	6.6e-07	7.48e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—HRAS—germ cell cancer	6.31e-07	7.15e-06	CbGpPWpGaD
